About us
History and Timeline
2017
　 The Company acquires the dealership of Lemon Eucalyptus Oil Mosquito Repellents products from New Zealand Skin Technology.
May The company passes the assessment of compliance against the GDP requirements conducted by TFDA.
2016
May The company passed the PIC / S GMP routine inspection conducted by TFDA, and its manufacturing license was extended.
Jul Mr. HO, MIN-TING took over the position of chairman.
2013
Feb The new factory was inaugurated for penicillin manufacturing.
Sep The company passed the inspection conducted by Japan Pharmaceutical and Medical Devices Agency (PMDA).
2012
Jan HSINCHUANG pharmaceutical factory passed through the routine inspection conducted by TFDA.
Sep The staff dormitory was established and opened.
Nov The company was commended by the Ministry of Economic Affairs, and granted a certificate of recognition for good corporate.
2011
Feb HSINCHUANG pharmaceutical factory passed through the for cause inspection conducted by TFDA.
Jul Completed was the "expansion construction project of factory zone for infusion fluid products” at HSINCHUANG Pharmaceutical Factory.
2010
May Mr. HO, YAO-TING took over as the chairman.
May Completed was the “expansion construction project of factory zone equipped with new sterilization facilities” at HSINCHUANG Pharmaceutical Factory.
2008
Apr The company was approved to apply the "Green Mark “issued by EPA, on its product- medical grade polyethylene infusion containers.環保標章」
2007
Jan The company set up the Beauty Salon in Dunhua South Road, distributing the “Clean Shu Shu” and “Dr. Devias,”and established Yuen Foong Technology INC..
2006
　 The company acquired the dealership of electrolysis alkaline ionized water, “Clean Shu! Shu!” from Chemicoat Co., Ltd.
2004
Oct TFDA approved and notified via correspondence that the company had completed the phase-three validation of "Good Manufacturing Practices".
2003
Nov TFDA approved and notified via correspondence that the company had completed the phase-two validation of "Good Manufacturing Practices, “in compliance with the revised requirements of ISO-9001 (2000 Edition).
2001
Oct TFDA approved and notified via correspondence that the company had completed the phase-one validation of "Good Manufacturing Practices".
1997
Jul The company was assessed as an ISO-9002 certified factory with good manufacturing practices.
1995
May The expansion was completed of the company’s test and research building.
1994
Mar The construction of synthetic pilot plant was completed and certified to inaugurate.
Jul The expansion of second production line was completed and operated, for soft bagged infusion fluid.
Sep Antibiotic synthesis plant and sewage treatment plant was completed. A joint venture was established between the company and the US BAXTER, which is BAXTER Taiwan, to distribute infusion fluid products and the series medical products of BAXTER.
1992
　 The company celebrated its fortieth anniversary and the construction of its office building was completed. In the year, the company engaged in a technical cooperation with Japan CHUGAI Pharmaceutical Co., Ltd., and commenced production of GLYCEOL injection and ULSANIC tablet.
1989
　 Mr. HO, JIAN-TING took over as the chairman.
1987
　 G.M.P. comprehensive pharmaceutical factory was established and inaugurated, and the company engaged in a technical cooperation with the US BAXTER TRAVENOL Corporation, and set up a soft bagged infusion fluid production line. The factory received visitors from all social circles.
1978
　 The company engaged in a technical cooperation with Italian Rottapharm, commencing production of active pharmaceutical ingredients, AMPICILLIN and AMOXICILLIN.
1972
　 The equipment at Sanchong Plant was completely relocated to HSINCHUANG Factory.
1967
　 Synthetic Factory Three (LACTONE) was built. Our synthesis plant for CHLORAMPHENICOL was inspected and qualified by the United States FDA, and the company commenced to produce and oversea market the product.
1965
　 Synthetic Factory Two (ROBAL) was built, and served as a small pilot plant for synthesis.
1964
　 Mr. HO Rongting took over as the chairman of the board. In the same year, the company engaged in a technical cooperation with Japan IWAKI SEIYAKU CO., LTD., and commenced production of active pharmaceutical ingredients such as SULPYRIN and TAURINE at Synthetic Factory One.
1963
　 In adjacent to HSINCHUANG Pharmaceutical Factory, an expanded plastic factory was set up, for which the company imported a West German 4,000-ton hydraulic equipment for the production of Melamine film board, and completed the relevant trademark registration. In the same year, the company completed the development of PE bag products.
1962
　 HSINCHUANG Pharmaceutical Factory was constructed and commenced to operate.
Aug Our plastic products were awarded the CNS Mark, which means the product meets national standards.
1960
　 The company engaged in a technical cooperation with West Germany Bayer Dye Pharmaceutical Company, commencing production of MOLTOPLAN at Sanchong Plant.
1959
　 The company engaged in a technical cooperation with West Germany C.F. BOEHRINGER, and commenced production of PARAXIN capsule.
1957
　 A small synthesis plant was set up for trial production of various raw materials.
1956
　 Mr. HO, YI, the founder, passed away, and Mr. HO, CHUAN took over as the new chairman.
1955
　 An extended factory was set up for aseptic packaging in line with international standards.
1953
　 The company engaged in a technical cooperation with Japan CHUGAI Pharmaceutical Co., Ltd., and commenced production of injection.
1952
　 On October 10, the Sanchong Plant was established and inaugurated, producing pharmaceuticals, and soft tube and plastic film made from PVC. The plant received visitors from all social circles.